Nursing · Independent exam preparation
Certified Dialysis Nurse (CDN) Preparation Guide Study Guide
Practise hemodialysis assessment, fluid decisions, access safety, medication administration, kidney disease interpretation, AKI monitoring, and dialysis-water safety for the NNCC CDN exam.
By CertMedbry · Updated 27 October 2026
Build the reasoning needed to recognize dialysis complications, interpret laboratory trends, assess vascular access, and connect treatment delivery with patient outcomes. This guide follows NNCC's Certified Dialysis Nurse examination for registered nurses practising in-center hemodialysis. Its 60 selected concepts cover all four current domains; the official blueprint and specifications define the full examination scope. Original questions and flashcards support independent study and do not predict an examination result.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification and jurisdiction does this guide address?
This guide addresses NNCC's Certified Dialysis Nurse examination. The published eligibility requirements specify a full, unrestricted RN license in the United States or its territories, at least 2,500 qualifying hours within the preceding two years, and 30 approved nephrology continuing-education contact hours within that period. Qualifying practice concerns patients requiring in-center hemodialysis, including relevant staff education or supervision.
How many questions are administered, and how long is the examination?
NNCC administers 150 questions in three hours. Its June 2026 application booklet states on printed page 11 that about 25 questions are experimental pilot questions that are not scored. Because the booklet says 'about,' an exact scored-item count should not be inferred.
NNCC — CDN · NNCC Certification Examination Application Booklet — Revised June 2026
What delivery method and question styles does NNCC describe?
NNCC describes computer-based testing arrangements and gives examination instructions referring to four answer choices. Its official practice examination uses multiple-choice questions. The 20 questions in this guide are independent four-option, single-best-answer drills.
Which blueprint applies, and what are its domain weights?
The standalone blueprint and specifications are revised April 2026 and effective September 1, 2026. They assign Chronic HD Unit (ESRD) 52%, Concepts of Kidney Disease in Adults 32%, Chronic HD Unit (AKI & DGF) 8%, and Water for Dialysis 8%. The June 2026 application booklet repeats these weights and effective date but labels its embedded blueprint revised March 2026. This guide follows the April standalone documents.
CDN New Test Blueprint · Certified Dialysis Nurse Examination — Weights for Blueprint Categories · NNCC Certification Examination Application Booklet — Revised June 2026
How do the examination objectives cross the content domains?
The specifications assign pathology and complications 18%, interventions 22%, physiologic and technical principles 20%, teaching 10%, medications 14%, infection control 8%, and collaboration/administration 8%. These objectives cross the four content domains. Study a clinical problem through several objectives—for example, hypotension through physiology, intervention, medication review, and patient teaching.
Certified Dialysis Nurse Examination — Weights for Blueprint Categories
What passing standard does NNCC publish?
NNCC's publications contain a discrepancy. The CDN webpage states a standard score of 95 and describes this as answering 70% of test questions correctly. The June 2026 application booklet states approximately 74% on printed page 6 and about 74% on printed page 11. Neither percentage should be presented as an undisputed current requirement or converted into an invented raw-score calculation. Obtain clarification from NNCC when confirming the applicable passing standard. Performance on these independent learning questions does not establish readiness to pass.
NNCC — CDN · NNCC Certification Examination Application Booklet — Revised June 2026
Does this guide cover other NNCC pathways or historical CDN scope?
NNCC lists separate CNN, CNN-NP, practical/vocational nurse, and technician credentials. This guide selects the current CDN RN pathway and its in-center hemodialysis outline. Peritoneal dialysis and general transplantation are not separate domains in that outline; delayed graft function appears within Chronic HD Unit (AKI & DGF). Examination changes should also be distinguished from NNCC's arrangements for existing certificants.
NNCC — CDN · CDN New Test Blueprint · Attention All Current CDN and CNN Certificants — January 19, 2026
How is this guide weighted, and what remains outside its selected concepts?
The guide allocates 31 concepts to ESRD care, 19 to adult kidney disease, five to AKI/DGF, and five to water. Questions and flashcards each use a 10/6/2/2 distribution. These approximate the official percentages at small item counts. The 60 concepts are selective: use the complete official outline, specifications, and issuer reference list to identify additional learning needs.
CDN New Test Blueprint · Certified Dialysis Nurse Examination — Weights for Blueprint Categories · NNCC — CDN
The official credential is Certified Dialysis Nurse (CDN), issued by the Nephrology Nursing Certification Commission. The workbook wording 'Certified in Dialysis Nursing' refers here to that examination and does not establish a separate credential. This guide follows the US RN in-center hemodialysis pathway, rather than NNCC's CNN, CNN-NP, practical/vocational nurse, or technician examinations.
Outline used: NNCC CDN blueprint and test specifications revised April 2026, effective September 1, 2026; verified for October 10, 2026. The assigned workbook label, 'Certified in Dialysis Nursing (CDN)', maps to the official Certified Dialysis Nurse (CDN) Examination. The canonical slug is preserved; the workbook wording does not identify a separate examination.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Chronic HD Unit (ESRD)52%
1.How does diffusion remove small solutes during hemodialysis?
Diffusion moves dissolved substances across the dialyzer membrane down concentration gradients. Blood and dialysate remain in separate compartments, while selected solutes cross the membrane. Urea generally moves from blood into dialysate because its concentration is higher in blood. Dialysate composition determines other gradients, so movement is substance-specific. The discriminating principle is that solute removal by diffusion differs from fluid removal driven by a pressure gradient.
Apply it
A learner attributes falling blood urea entirely to fluid removal. Explain that urea crosses the membrane along its concentration gradient, while net water removal is controlled separately through the prescribed ultrafiltration process during treatment.
Common pitfall: Do not assume that every substance moves out of blood or that greater fluid removal necessarily means proportionately greater small-solute clearance.
2.Why do blood and dialysate flow in opposite directions?
Countercurrent flow exposes blood to dialysate moving in the opposite direction. This arrangement helps maintain concentration differences along the dialyzer rather than allowing the two streams to approach equilibrium early. A sustained gradient supports continuing diffusion throughout the device. The useful distinction is between maintaining a favorable gradient and simply circulating more fluid: direction contributes to exchange efficiency even though blood and dialysate remain physically separated by the membrane.
Apply it
During orientation, a nurse asks why dialysate does not travel alongside blood in the same direction. Use a diagram to show how opposite flow preserves a concentration difference over more of the dialyzer.
Common pitfall: Countercurrent flow does not mean blood mixes with dialysate. Direct mixing would represent loss of the membrane barrier, rather than normal exchange physiology.
3.What distinguishes ultrafiltration from diffusive clearance?
Ultrafiltration removes plasma water across the dialyzer membrane through a pressure gradient. Diffusion primarily describes solute movement along concentration gradients. These processes occur together but answer different clinical needs: removing accumulated extracellular fluid and reducing retained solutes. A patient can achieve satisfactory urea clearance while remaining fluid overloaded. Conversely, removing the planned fluid volume does not prove adequate solute clearance or satisfactory tolerance of the treatment.
Apply it
A patient reaches the prescribed postdialysis weight but has repeatedly shortened treatments and poor urea clearance. Separate the successful fluid outcome from the incomplete solute-removal assessment when discussing the treatment with the team.
Common pitfall: Reaching a weight target is not a substitute for evaluating treatment time, delivered clearance, symptoms, and the broader adequacy of dialysis care.
NIDDK — Hemodialysis · National Kidney Foundation — Hemodialysis: How It Works, Types, and What to Expect
4.How is a planned ultrafiltration volume calculated?
A planning calculation starts with predialysis weight minus the intended postdialysis target weight, using approximately one kilogram per liter of water. Add anticipated fluid inputs during treatment and subtract separately measured outputs when those assumptions apply. Dividing the planned removal by treatment hours gives an average volume rate. The arithmetic describes the proposed prescription; it does not establish that the target weight or resulting removal rate is clinically tolerable.
Apply it
Predialysis weight is 73.4 kg and target weight is 71.0 kg. With 0.3 L of anticipated intake and no other outputs, planned removal is 2.7 L, averaging 675 mL/hour over four hours.
Common pitfall: Do not omit treatment fluid inputs or confuse the calculated volume with automatic authorization to remove it despite hypotension or other intolerance signs.
5.How should target weight change when body composition changes?
Target weight estimates a postdialysis weight compatible with acceptable volume status and treatment tolerance. It is not a permanent measurement of body size. Loss of muscle or fat can conceal extracellular fluid excess even when the scale repeatedly reaches the previous target. Conversely, tissue gain can make an unchanged target excessively low. Interpret weight alongside symptoms, blood pressure patterns, examination findings, residual urine output, and the patient's recent clinical course.
Apply it
After several weeks of poor intake, a patient reaches the old target weight but develops worsening edema and breathlessness. Recognize that tissue loss may be masking retained fluid and request reassessment of volume status.
Common pitfall: A familiar target weight is not proof of euvolemia. Avoid treating either one scale reading or one blood pressure as a definitive assessment.
6.Which findings support clinically important fluid overload?
Fluid overload develops when intake and sodium retention exceed excretion and dialysis removal. Findings can include increasing weight, edema, breathlessness, elevated blood pressure, and pulmonary congestion. No single sign measures total volume accurately; trends and the combined examination are more useful. New respiratory distress requires urgent assessment because excess fluid can impair gas exchange. The clinical question is both whether overload exists and how safely the excess can be removed.
Apply it
A patient arrives above usual weight with new orthopnea, swollen ankles, and higher blood pressure. Assess respiratory status promptly and communicate the combined findings instead of reporting only the number of kilograms gained.
Common pitfall: Absence of ankle edema does not exclude fluid overload. Likewise, hypertension alone does not prove that aggressive fluid removal is the correct intervention.
National Kidney Foundation — Fluid Overload in a Dialysis Patient · KDIGO — Blood Pressure and Volume Management in Dialysis
7.Why can blood pressure fall during fluid removal?
Ultrafiltration reduces circulating plasma volume. Blood pressure may fall when fluid removal exceeds vascular refilling and cardiovascular compensation. Risk therefore depends on more than the total volume removed: treatment time, cardiac function, vascular responses, medications, and the selected target weight matter. Symptoms such as dizziness, nausea, or presyncope make a falling pressure clinically meaningful. Recurrent episodes should trigger review of the entire volume-management strategy rather than acceptance as an inevitable treatment effect.
Apply it
A patient becomes dizzy during a session with a large removal goal over shortened treatment time. Connect the symptoms to possible inadequate vascular refilling and assess the patient and treatment parameters immediately with the team.
Common pitfall: Do not attribute every pressure decline to the same mechanism. Infection, bleeding, arrhythmia, and other acute problems can also require urgent clinical assessment.
8.How should symptomatic intradialytic hypotension guide intervention?
Symptomatic hypotension calls for immediate assessment and reduction or cessation of ultrafiltration under the unit's response procedure. Positioning, reassessment of circulation, and prescribed fluid support may be needed while alternative causes are considered. The immediate goal is restoring perfusion, not completing an unchanged removal target. After stabilization, review the target weight, treatment duration, interdialytic gain, and medication timing to reduce recurrence without leaving chronic fluid overload unaddressed.
Apply it
During dialysis, a patient's pressure falls sharply with dizziness and clammy skin. Assess circulation and reduce or stop ultrafiltration according to protocol, then reassess response and escalate persistent instability for urgent medical evaluation.
Common pitfall: Continuing the same removal rate to reach the prescribed weight can worsen hypoperfusion. Stabilization and subsequent prescription review are separate, necessary clinical decisions.
9.Why does treatment duration matter for fluid tolerance?
For the same removal volume, a longer treatment distributes ultrafiltration across more time and lowers the average removal rate. This can improve the balance between removal and vascular refilling. Simply compressing the same goal into a shorter session increases physiologic stress. Duration also contributes to solute clearance, so shortening treatment can impair two outcomes simultaneously. Decisions about additional time should consider symptoms, volume burden, patient circumstances, and the prescribed treatment plan.
Apply it
A patient requests three hours instead of four while retaining a 3 L removal goal. Calculate that the average rate would rise from 750 to 1,000 mL/hour and discuss safer treatment options.
Common pitfall: An unchanged total removal volume does not mean an unchanged treatment burden. Avoid judging tolerance without considering the time available for fluid removal.
10.How do vascular access types differ in infection risk?
A fistula uses a surgically connected native artery and vein, a graft uses an implanted conduit, and a catheter provides direct access through an indwelling tube. Infection risk is generally lowest with fistulas and highest with central venous catheters, with grafts between them. Catheters create an ongoing route from the skin and external connections into the bloodstream. Access selection also requires individualized assessment of anatomy, clinical needs, and feasible long-term care.
Apply it
A patient says a catheter seems preferable because it avoids needle insertion. Explain the bloodstream infection disadvantage and support a discussion of suitable longer-term access choices with the nephrology and access teams during care planning.
Common pitfall: Lower average infection risk does not make an access infection-proof. Every access still requires assessment, hygiene, and prompt evaluation of concerning new symptoms.
CDC — Infections and Patients on Dialysis · Hemodialysis Access | National Kidney Foundation
11.When does a changed access thrill require urgent action?
The palpable thrill reflects blood moving through a functioning fistula or graft. A newly absent or markedly changed thrill may indicate impaired flow, including thrombosis or significant obstruction. Compare with the patient's baseline and report the change promptly for assessment before routine use. The discriminating cue is a new change in function, even without pain or redness. Waiting for the next scheduled treatment can reduce opportunities to preserve a threatened access.
Apply it
Before cannulation, a patient reports that the fistula stopped buzzing overnight. You cannot feel the usual thrill. Withhold routine cannulation and promptly arrange access assessment rather than assuming the absence of pain is reassuring.
Common pitfall: Do not attempt to establish function by repeatedly inserting needles. A new absent thrill calls for evaluation rather than a trial of routine dialysis.
12.How can patients protect a fistula or graft between treatments?
Protecting access means reducing compression, trauma, and contamination while detecting changes early. Patients should check the access as taught, keep it clean, and report altered function or signs of infection. Avoiding blood pressure cuffs and unnecessary venipuncture in the access arm helps protect the access circulation and vessels. Teaching is most useful when the patient can explain what the normal thrill feels like and whom to contact when it changes.
Apply it
At a clinic visit, a patient is directed to offer the fistula arm for blood pressure measurement. Practise a short explanation the patient can use to request the other arm and identify the protected access.
Common pitfall: Access protection is not avoidance of all normal arm use. Give specific precautions and symptom reporting instructions instead of creating unnecessary fear of movement.
13.Why must catheter hubs be disinfected at every connection?
A catheter hub connects an external surface with a pathway into the bloodstream. Organisms on that surface can enter during manipulation, even when the site appears clean. CDC recommends standardized hub disinfection whenever the catheter is accessed or disconnected, using the selected product and required technique. Effective practice includes appropriate friction and drying rather than a quick visual check. An intact dressing does not replace disinfection of the separate hub connection.
Apply it
A catheter dressing is clean and dry, and a colleague proposes connecting immediately. Explain that the hub remains a distinct contamination route and complete the required disinfection and drying process before making the connection.
Common pitfall: Do not substitute sterile-looking equipment or clean gloves for hub disinfection. Each barrier addresses a different opportunity for organisms to enter the circulation.
CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
14.How does skin antisepsis prevent access-related bloodstream infection?
Skin antisepsis reduces organisms at the site where a needle or catheter crosses the skin barrier. CDC favors an alcohol-based chlorhexidine solution for central-line insertion and dressing changes when appropriate, with suitable alternatives when contraindicated. The chosen product must be applied correctly and allowed to dry. Subsequent touching can recontaminate the prepared area. Product selection, application technique, and preservation of the prepared field work together; none can substitute for the others.
Apply it
After cleaning a catheter site, a nurse reaches to touch it while arranging supplies. Recognize that the prepared area may be contaminated and restore the required aseptic conditions before continuing with the dressing procedure.
Common pitfall: Do not rush drying or assume every patient tolerates the same antiseptic. A documented contraindication requires an appropriate alternative, not omission of skin preparation.
CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
15.Why are hand hygiene and glove changes both necessary?
Hands and gloves can transfer organisms between surfaces, equipment, and vascular access. Gloves provide a barrier but become contaminated during care and do not replace hand hygiene. Moving from a contaminated task to an aseptic task requires the appropriate glove change and hand hygiene sequence. In dialysis, frequent contact with the machine, charting surfaces, and blood tubing creates repeated opportunities for transfer. The key distinction is the task transition, not whether gloves remain visibly clean.
Apply it
A nurse touches a used dressing and then reaches toward a disinfected catheter hub with the same gloves. Identify the contaminated-to-aseptic transition and interrupt the sequence for appropriate glove removal, hand hygiene, and fresh gloves.
Common pitfall: Visible cleanliness is an unreliable measure of microbial contamination. Wearing one pair of gloves throughout a patient's session can spread organisms across separate tasks.
CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
16.How does clean medication preparation reduce dialysis infection risk?
Medication preparation should occur in a designated clean area separated from contaminated treatment supplies and used equipment. Injection safety prevents organisms from moving through shared preparation surfaces, syringes, needles, or medication containers. A new sterile needle and syringe are required for each injection and patient. Dialysis workflow must preserve this separation even during busy turnover periods. Convenience at the chairside does not justify bringing shared medication supplies into an environment where blood contamination may occur.
Apply it
During turnover, a staff member places shared medication preparation supplies beside used blood tubing. Move preparation back to the designated clean area and address the workflow that allowed contaminated equipment to enter that space.
Common pitfall: Changing only the needle does not make a used syringe safe. Injection safety depends on the entire preparation and administration process for each patient.
CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
17.How should bloodstream infection surveillance guide improvement?
Surveillance makes infection patterns visible by consistently identifying events and relating them to an appropriate population or exposure measure. Tracking access type helps interpret risk because catheter-dependent populations differ from fistula populations. CDC supports sharing surveillance findings with staff and using them to improve practice. A rising pattern should prompt investigation of prevention processes, rather than speculation about one employee. Consistent definitions and comparable denominators are necessary before judging whether performance has changed.
Apply it
A unit reports more bloodstream infections after its catheter population increases. Examine access-specific rates and observe catheter-care practices before concluding that the raw event count proves deterioration in every aspect of infection prevention.
Common pitfall: Raw counts alone can mislead when patient volume or access mix changes. Surveillance should support investigation and feedback, not replace direct assessment of practice.
CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
18.Why should access-care competency be observed directly?
Knowledge of an infection-prevention policy does not ensure reliable performance during actual catheter or vascular access care. Direct observation can reveal missed friction, incomplete drying, contaminated glove transitions, and other technique failures. CDC recommends staff education, competency assessment, and audits with feedback. The useful decision is to target the demonstrated gap and reassess performance. Attendance at an education session documents participation; it does not by itself demonstrate safe execution of the procedure.
Apply it
All staff completed annual education, yet an audit finds inconsistent catheter hub drying. Provide focused demonstration and supervised return demonstration, then repeat observations to determine whether the specific technique has improved in routine practice.
Common pitfall: Avoid responding to every practice failure with another generic lecture. Feedback is more useful when it identifies the observed step and verifies corrected performance.
CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
19.Which assessments make extracorporeal heparin administration safer?
Anticoagulation helps prevent clotting as blood contacts extracorporeal surfaces. Before heparin administration, verify the prescribed dose and concentration, assess active bleeding and recent procedures, and check for a history of heparin-induced thrombocytopenia. Monitor bleeding, platelet trends, and hematocrit; coagulation testing depends on the regimen. The [heparin sodium prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=295ea9c6-d08c-40f0-a908-de0fdac44644) identifies uncontrolled active bleeding and prior HIT as contraindications. New thrombocytopenia or thrombosis requires prompt assessment for HIT, which can cause thrombosis despite a falling platelet count.
Apply it
A patient receiving routine circuit heparin develops new thrombocytopenia and a thrombotic complication. Stop further heparin exposure under the emergency medication procedure and obtain urgent prescriber assessment for HIT rather than increasing heparin to address clotting.
Common pitfall: Do not assume circuit clotting always means insufficient anticoagulant. Patient bleeding risk, HIT, prescription accuracy, and circuit conditions require assessment before additional medication.
20.Why are phosphate binders usually taken with food?
Phosphate binders act in the gastrointestinal tract by binding phosphorus from food and reducing its absorption. Their effect therefore depends on contact with a phosphorus-containing meal or snack. Taking the same tablets long after eating can reduce their intended benefit. Persistent hyperphosphatemia should prompt assessment of timing, food choices, tolerability, access to medication, and the prescribed regimen. Sevelamer is contraindicated in bowel obstruction; severe new gastrointestinal symptoms warrant prompt assessment and treatment review.
Apply it
A patient takes all prescribed binder tablets at bedtime because that is easiest to remember. Ask about meal patterns and teach how the prescribed doses should accompany food, using the patient's usual daily routine.
Common pitfall: Binders do not remove phosphate already circulating in blood. Avoid describing them as a rescue treatment that works equally well regardless of meal timing.
NIDDK — Treat Complications & Comorbidities · DailyMed - SEVELAMER CARBONATE tablet, film coated
21.How is the urea reduction ratio calculated and interpreted against common adequacy benchmarks?
The urea reduction ratio (URR) describes the proportional decline in blood urea during treatment: URR = [(predialysis BUN − postdialysis BUN) / predialysis BUN] × 100. For many adults receiving conventional thrice-weekly in-center hemodialysis, commonly used minimum delivered small-solute clearance measures are URR at least 65% or single-pool Kt/V at least 1.2. Meeting a minimum supports satisfactory measured urea removal but does not establish overall treatment adequacy. Prescription interpretation also depends on treatment frequency, duration, body size, and residual kidney function. Residual clearance must be assessed when it is used to justify a different dialysis dose.
Apply it
With predialysis BUN of 72 mg/dL and postdialysis BUN of 24 mg/dL, URR = (48 / 72) × 100 = approximately 67%, meeting the commonly used 65% minimum. If postdialysis BUN were instead 30 mg/dL, URR would be approximately 58%, below that benchmark. Review sampling technique and timing, actual delivered treatment time, interruptions, effective blood flow, and access function. Shortened treatments reduce clearance time; poor access flow or recirculation can reduce effective solute removal. Interpret the findings alongside symptoms, potassium and other laboratory trends, volume control, nutrition, and treatment tolerance.
Common pitfall: Use predialysis BUN as the denominator. Do not interpret a URR of 67% as proof that fluid removal, nutrition, or symptom control is satisfactory. Conversely, a below-benchmark result requires investigation of measurement validity and treatment delivery rather than an assumption that the patient simply needs a higher pump setting. URR and single-pool Kt/V describe related aspects of urea clearance but are different measures; neither minimum automatically determines the appropriate prescription for every schedule or level of residual kidney function.
National Kidney Foundation — Hemodialysis: How It Works, Types, and What to Expect
22.What does Kt/V represent in hemodialysis assessment?
Kt/V relates dialyzer urea clearance, K, multiplied by treatment time, t, to the patient's urea distribution volume, V. It expresses a dose of small-solute clearance relative to body water. Delivered time, effective clearance, and patient characteristics therefore affect interpretation. Kt/V is useful for monitoring a major treatment component, but it cannot by itself establish satisfactory volume status, nutrition, access health, or symptom control. Those outcomes require their own assessments.
Apply it
A patient repeatedly finishes dialysis early and asks why treatment time matters when the machine runs normally. Explain that time contributes directly to delivered clearance and that shortening treatment can reduce the dose received.
Common pitfall: A machine setting is not equivalent to a verified delivered dose. Avoid treating Kt/V as a comprehensive score of every aspect of dialysis care.
National Kidney Foundation — Hemodialysis: How It Works, Types, and What to Expect
23.How should intravenous-iron reactions be recognized and managed?
Before intravenous iron, verify the formulation, ordered dose and rate, previous reactions, iron studies, and baseline blood pressure. Administer it where trained personnel and emergency therapies are immediately available. Sudden wheezing, dyspnea, hypotension, or collapse suggests a serious hypersensitivity reaction. Stop iron immediately, summon emergency assistance, and support airway, breathing, and circulation. For suspected anaphylaxis, give immediate intramuscular epinephrine under authorized emergency orders. RCUK guidance specifies an adult dose of 0.5 mg, equivalent to 0.5 mL of the 1 mg/mL solution, repeated after five minutes if improvement is absent. Antihistamines must not delay epinephrine because they do not reverse life-threatening breathing or circulatory compromise. Iron sucrose requires monitoring throughout administration and for at least 30 minutes afterward, until clinically stable.
Apply it
Minutes after iron sucrose begins, a previously stable patient develops wheezing and a blood pressure of 72/40 mmHg. Treat this as suspected anaphylaxis: stop iron, activate emergency assistance, administer intramuscular epinephrine immediately under authorized orders, and support oxygenation and circulation. Give ordered intravenous crystalloid with repeated assessment of the response. Reassess continuously and repeat epinephrine after five minutes if improvement is absent.
Common pitfall: Previously tolerated doses do not exclude a new serious reaction, and anaphylaxis can occur without a rash. Wheezing with circulatory collapse must not be attributed solely to ultrafiltration or managed merely by slowing iron. Antihistamines are adjuncts for appropriate symptoms after urgent treatment; they cannot replace or postpone epinephrine.
KDIGO-2026-Anemia-in-CKD-Guideline.pdf · Special circumstances Guidelines | Resuscitation Council UK · DailyMed - VENOFER- iron sucrose injection, solution
24.How do missed or shortened treatments affect risk?
Missed or shortened treatments reduce the time available to remove retained solutes and accumulated fluid. The next session may then involve both greater biochemical burden and a larger removal requirement. This can increase the challenge of delivering dialysis safely within limited time. Assessment should identify the actual barrier, such as transportation, symptoms, work, or distress. Effective intervention connects the clinical consequences with a practical plan that makes prescribed treatment more achievable.
Apply it
A patient leaves early twice weekly to catch transportation. Review the resulting loss of treatment time and coordinate a scheduling or transport solution rather than repeatedly documenting the early departures without addressing their cause.
Common pitfall: Do not assume missed treatment reflects lack of concern. A technically sound prescription cannot achieve its intended benefit when practical barriers repeatedly prevent delivery.
National Kidney Foundation — Hemodialysis: How It Works, Types, and What to Expect · NIDDK — Lesson 5: Getting Ready for Treatment
25.Which foods count toward a dialysis fluid allowance?
Fluid intake includes beverages and foods that are liquid at room temperature, such as ice, gelatin, and many frozen desserts. Soups and similar foods also contribute substantial water. The allowance should be individualized to urine output, dialysis schedule, weight trends, and the treatment plan. Accurate accounting explains unexpected interdialytic gain and supports practical choices. Counting only water drunk from a glass can substantially underestimate the amount entering the body.
Apply it
A patient reports drinking little but eats ice throughout the day and has soup with both meals. Include these sources in a shared intake review and relate the total to interdialytic weight changes.
Common pitfall: Avoid giving every patient the same fluid allowance. Residual urine output and clinical circumstances differ, and hidden fluid sources can explain apparent inconsistencies.
26.Why does sodium reduction help control interdialytic weight gain?
Sodium promotes thirst and contributes to extracellular fluid retention when kidney excretion is limited. High-sodium meals can therefore make a fluid plan harder to follow and increase the amount requiring removal at the next treatment. Reviewing processed foods, restaurant meals, and added salt may reveal a modifiable cause of large gains. Education should connect sodium exposure with thirst and volume burden rather than framing fluid control only as an exercise in resisting drinks.
Apply it
A patient reports intense thirst after packaged noodles and cured meats. Review their sodium content and identify lower-sodium alternatives, explaining how this change may make the agreed fluid plan easier to follow between treatments.
Common pitfall: Do not recommend salt substitutes automatically. Some contain potassium, which can create a separate safety problem for a patient with limited potassium excretion.
National Kidney Foundation — Fluid Overload in a Dialysis Patient · NIDDK — Eating & Nutrition for Hemodialysis
27.How should nutrition advice change for a patient receiving hemodialysis?
Hemodialysis changes nutritional priorities because treatment removes some nutrients and patients need adequate protein and energy to maintain tissue. A restriction remembered from earlier CKD care may no longer fit the current treatment stage. Potassium, phosphorus, sodium, and fluid advice should reflect laboratory trends, intake, and individual needs. A renal dietitian can reconcile competing goals, especially when food avoidance is causing inadequate intake or weight loss rather than safer biochemical control.
Apply it
A patient starting hemodialysis continues a very low-protein eating pattern and loses weight. Arrange renal dietitian review to develop adequate protein and energy intake while addressing the patient's actual potassium, phosphorus, sodium, and fluid concerns.
Common pitfall: Avoid describing a single universal renal diet. Broad food prohibitions can worsen intake when treatment stage, laboratory findings, and nutritional risks require individualized choices.
28.How can teach-back reveal a dialysis education gap?
Teach-back asks the patient to explain or demonstrate a plan in their own words. It tests how clearly the information was communicated rather than asking whether the patient understood. Concrete tasks reveal misunderstandings that agreement or nodding may conceal. For dialysis education, useful tasks include describing binder timing, showing an access check, or explaining whom to call about a changed thrill. Correct the specific gap and repeat the task with simpler, relevant language.
Apply it
After discussing binders, ask a patient to describe when tablets would be taken with tomorrow's usual meals. If the answer is bedtime, reteach using the actual meal schedule and check the explanation again.
Common pitfall: Do not make teach-back feel like an examination of intelligence. A missed explanation should trigger clearer teaching and support rather than blame or embarrassment.
29.How should transportation problems be incorporated into treatment planning?
Transportation is part of treatment feasibility because in-center hemodialysis requires reliable attendance for scheduled sessions. Repeated lateness or early departure may reflect a mismatch between transport arrangements and prescribed treatment time. Ask about pickup windows, cost, mobility, and backup options. Coordinate with the appropriate team members to address the specific obstacle. A plan is clinically useful when it increases the likelihood that the patient can receive the treatment actually prescribed.
Apply it
A shared ride routinely arrives before treatment finishes, and the patient fears being stranded. Involve social work and scheduling staff to negotiate workable transport timing while explaining the clinical importance of completing prescribed sessions.
Common pitfall: Repeating attendance advice does not solve an unavailable ride. Distinguish a knowledge gap from a resource problem before selecting an intervention for missed treatment.
30.How do psychological and cultural factors shape dialysis education?
Kidney failure can alter independence, family roles, employment, food practices, and expectations about illness. Anxiety or distress may reduce attention and make a technically correct explanation ineffective. Ask which concerns matter most and adapt teaching to language, health literacy, cultural food patterns, and the patient's chosen supports. Respectful inquiry avoids assuming that one approach fits a whole group. Education works better when the plan connects medical goals with the patient's daily life.
Apply it
A patient avoids discussing diet because previous advice seemed to reject customary family foods. Ask about usual dishes and involve a renal dietitian to identify workable modifications while preserving meaningful foods and family participation.
Common pitfall: Do not infer beliefs or preferences from ethnicity alone. Cultural responsiveness begins with the individual's account and does not justify stereotyping or excluding patient choices.
31.Which findings require review before administering an ESA?
Check blood pressure, hemoglobin trajectory, iron availability, and the current ESA order. KDIGO 2026 recommends an adult maintenance hemoglobin target below 11.5 g/dL because higher targets increase vascular risks. Product-specific instructions also apply: the [Epogen prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5) contraindicates uncontrolled hypertension and directs dose reduction or interruption as hemoglobin approaches or exceeds 11 g/dL in adults on dialysis. A rise exceeding 1 g/dL over two weeks also calls for dose reduction. These are clinical guidance and labeling criteria, rather than examination scoring rules.
Apply it
An adult on hemodialysis has hemoglobin rising from 9.8 to 11.2 g/dL in two weeks, with the previous epoetin order unchanged. Flag the rapid rise and dialysis-specific label threshold, obtain dose review, and implement the authorized adjustment before administration.
Common pitfall: Do not aim to normalize hemoglobin or automatically escalate an ESA for a poor response. Investigate iron restriction, inflammation, and blood loss, and use the lowest effective prescribed dose.
Concepts of Kidney Disease in Adults32%
32.What establishes chronicity when diagnosing CKD?
CKD requires abnormalities of kidney structure or function with health implications that persist for at least three months. An eGFR below 60 mL/min/1.73 m² can establish the functional component when chronicity is demonstrated; persistent markers of kidney damage can establish CKD even at higher eGFR. One abnormal result during acute illness does not establish chronic disease. Previous laboratory results, repeat testing, imaging, and the clinical history help distinguish chronic disease from acute change.
Apply it
A patient with gastroenteritis has an eGFR of 48 for the first time. Review earlier kidney results and assess the acute illness rather than diagnosing CKD solely from this single abnormal laboratory measurement.
Common pitfall: Do not confuse an abnormal kidney test with proven chronicity. Acute kidney injury and CKD can also coexist, so historical abnormalities do not exclude new deterioration.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
33.Why classify CKD by cause, GFR, and albuminuria together?
KDIGO classifies CKD using cause, GFR category, and albuminuria category, often abbreviated CGA. Cause identifies the underlying disease process, GFR describes filtration, and albuminuria adds information about kidney damage and future risk. Patients with the same eGFR can therefore have different prognoses and management needs. Classification should preserve all three dimensions when known. A stage number based only on filtration loses clinically meaningful information about disease mechanism and risk.
Apply it
Two adults have the same eGFR, but one has much higher persistent urine albumin. Explain that equivalent filtration does not imply equivalent risk and include the albuminuria category in the clinical assessment and education.
Common pitfall: Do not use a GFR category as a complete diagnosis. The underlying cause and albuminuria can change the meaning of an otherwise identical filtration result.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
34.Which GFR categories distinguish moderate from severe reduction?
KDIGO GFR categories are G1 at least 90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, and G5 below 15 mL/min/1.73 m². G3a and G3b separate different degrees of moderately reduced filtration, while G4 indicates severe reduction. G1 or G2 alone does not establish CKD without another marker of kidney damage. Category assignment also does not independently determine whether dialysis should start in a particular patient.
Apply it
An adult has a stable eGFR of 38 over six months and persistent albuminuria. Identify G3b, then include albuminuria and cause rather than describing the patient only as having an isolated abnormal creatinine.
Common pitfall: Do not label every eGFR below 90 as CKD. Higher GFR categories require evidence of kidney damage, and chronicity must still be established.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
35.How are urine albumin categories assigned?
Urine albumin-to-creatinine ratio categorizes albuminuria as A1 below 30 mg/g, A2 from 30 through 300 mg/g, and A3 above 300 mg/g. The creatinine denominator helps account for urine concentration. Albuminuria adds risk information beyond eGFR and may identify kidney damage while filtration remains relatively preserved. Interpret results with chronicity and the clinical setting because temporary factors can raise albumin excretion. Persistent abnormality carries a different meaning from one isolated result.
Apply it
An adult has a urine albumin-to-creatinine ratio of 180 mg/g on repeated testing. Identify A2 albuminuria and interpret it alongside the patient's eGFR, likely kidney disease cause, and established duration of the abnormality.
Common pitfall: Do not compare results without checking units. Milligrams per gram and milligrams per millimole use different numerical category thresholds despite measuring the same relationship.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
36.Why are eGFR and urine albumin complementary tests?
Blood-based eGFR estimates filtration, while urine albumin testing detects abnormal leakage of albumin into urine. These assess related but different aspects of kidney health. Albuminuria can be present before a major fall in filtration, and low eGFR may occur without marked albuminuria. Using both reduces the chance of overlooking clinically important disease. A reassuring result from one test should not be used to dismiss a persistent abnormality in the other.
Apply it
A patient assumes that an eGFR of 84 rules out kidney disease despite repeatedly elevated urine albumin. Explain the difference between filtration and damage markers and why both results belong in the assessment.
Common pitfall: A normal-looking creatinine does not exclude kidney damage. Avoid treating the blood test as a replacement for urine albumin assessment in patients at risk.
37.When should an abnormal urine albumin result be confirmed?
An abnormal urine albumin result should be interpreted in context and generally confirmed with repeat testing. Exercise, infection, and other transient circumstances can alter albumin excretion, so one measurement should not automatically be treated as persistent kidney damage. Review sampling conditions and the patient's clinical state, then use follow-up results to assess persistence. Confirmation is especially important when a new result would change classification, counseling, or further evaluation of kidney disease.
Apply it
A patient has a newly elevated urine albumin result during an acute urinary infection. Arrange reassessment after the acute problem is addressed and explain why persistence matters before drawing conclusions about chronic kidney damage.
Common pitfall: Do not dismiss an abnormal result as temporary without follow-up. The alternative to premature labeling is confirmation, rather than assuming the finding will disappear.
NIDDK — Chronic Kidney Disease Tests & Diagnosis · KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
38.Why do diabetes and hypertension require kidney surveillance?
Diabetes and hypertension are important causes and risk factors for kidney disease. Kidney damage may develop before symptoms become obvious, so symptom-based screening misses opportunities for recognition. Blood pressure, eGFR, and urine albumin provide complementary information about risk and current kidney health. The presence of diabetes or hypertension does not prove the cause of every abnormal kidney result. An atypical pattern or rapid change warrants evaluation rather than automatic attribution to a familiar diagnosis.
Apply it
An adult with longstanding diabetes feels well and asks why urine albumin testing is needed. Explain that early kidney damage may be silent and that urine testing adds information not supplied by symptoms or eGFR alone.
Common pitfall: Do not assume the absence of pain or urinary symptoms excludes CKD. Also avoid assigning diabetic kidney disease without considering the overall clinical pattern.
NIDDK — Chronic Kidney Disease Tests & Diagnosis · KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
39.How do emergency hyperkalemia treatments protect the heart, redistribute potassium, and remove it?
Severe hyperkalemia with ECG changes requires urgent monitored treatment. Under applicable emergency orders, intravenous calcium counteracts cardiac toxicity but does not lower potassium. Insulin with glucose shifts potassium into cells temporarily; glucose monitoring is essential because delayed hypoglycemia can occur. Dialysis removes potassium from the body and may be required for refractory severe hyperkalemia. Recheck potassium because redistribution can wear off and potassium can rebound, including after dialysis. These treatment mechanisms reflect clinical guidance rather than examination rules.
Apply it
A patient has potassium of 6.8 mmol/L with new ECG changes. Prepare ordered calcium for immediate cardiac protection while the team initiates potassium-shifting therapy and arranges definitive removal when indicated. Continue ECG, glucose, and potassium reassessment.
Common pitfall: An improved ECG after calcium does not establish potassium removal. A lower potassium after insulin does not prove the excess has left the body or eliminate recurrence risk.
Special circumstances Guidelines | Resuscitation Council UK · National Kidney Foundation — High Potassium: Causes, Symptoms, and Treatment
40.Why can a low-sodium salt substitute be unsafe?
Some salt substitutes replace sodium chloride with potassium salts. A product marketed for sodium reduction can therefore increase potassium exposure in someone whose kidneys cannot excrete potassium effectively. Product labels, serving amounts, and the patient's laboratory pattern matter more than the marketing claim. This is a useful example of competing nutritional goals: reducing sodium should not unintentionally create a potassium hazard. Review substitutes and supplements explicitly because patients may not consider them medicines or relevant foods.
Apply it
A patient with recurrent hyperkalemia proudly reports replacing table salt with a low-sodium seasoning. Ask to review its ingredients and explain why potassium chloride may make that particular substitution unsuitable despite the sodium benefit.
Common pitfall: Do not assume all reduced-sodium products contain potassium or ban them without review. Identify the actual ingredients and fit advice to the patient's clinical needs.
National Kidney Foundation — High Potassium: Causes, Symptoms, and Treatment
41.How should medications be reviewed when potassium rises?
Hyperkalemia can reflect reduced excretion, medication effects, potassium supplements, and dietary sources acting together. Review prescription drugs, nonprescription products, and supplements rather than blaming food alone. Some medicines alter potassium handling while providing important kidney or cardiovascular benefits, so the response requires clinical review of indication, severity, and alternatives. Patients should report the complete regimen and obtain a specific plan. Unsupervised discontinuation can create new risks without adequately treating the potassium problem.
Apply it
A patient develops rising potassium after a medication change and also uses a potassium supplement. Reconcile both products and communicate the timing to the prescribing team instead of assuming fruit intake is the only explanation.
Common pitfall: Do not instruct patients to stop every potentially relevant medicine indefinitely. Medication benefit, potassium severity, and a safe monitoring plan must be considered together.
National Kidney Foundation — High Potassium: Causes, Symptoms, and Treatment · NIDDK — Keeping Kidneys Safe: Smart Choices about Medicines
42.Why does CKD reduce red blood cell production?
Healthy kidneys produce erythropoietin, a hormone that signals the bone marrow to make red blood cells. CKD can reduce that signal and contribute to anemia. However, kidney-related erythropoietin deficiency is only one mechanism: iron deficiency, inflammation, blood loss, and other deficiencies may coexist. A falling hemoglobin therefore requires assessment rather than automatic attribution to CKD alone. The important distinction is between a plausible chronic mechanism and the full explanation for a new change.
Apply it
A patient with CKD develops worsening fatigue and a lower hemoglobin. Explain the role of reduced erythropoietin while supporting assessment for iron deficiency, blood loss, and other contributors before assuming one mechanism explains everything.
Common pitfall: Do not equate all anemia in a patient with CKD with isolated erythropoietin deficiency. A new decline may reveal a separate, treatable clinical problem.
43.How do ferritin and transferrin saturation complement each other?
Ferritin helps assess iron stores, while transferrin saturation estimates the proportion of iron-binding capacity occupied by circulating iron. Both are useful because stored iron and iron available for red blood cell production are not identical. Inflammation can elevate ferritin and complicate interpretation, so a high value does not always mean adequate usable iron. Interpret the paired results with hemoglobin trends, clinical inflammation, blood loss, and treatment history rather than using either measurement alone.
Apply it
A patient has anemia, low transferrin saturation, and elevated ferritin during an inflammatory illness. Recognize that ferritin alone cannot exclude limited iron availability and bring the paired results and clinical context to the treatment review.
Common pitfall: Avoid treating ferritin as a direct measure of hemoglobin production. It is influenced by inflammation and must be interpreted with other iron and clinical information.
NIDDK — Treat Complications & Comorbidities · NIDDK — Anemia in Chronic Kidney Disease · KDIGO-2026-Anemia-in-CKD-Guideline.pdf
44.How does declining kidney function cause secondary hyperparathyroidism and bone disease?
Declining kidney function reduces phosphate excretion and the production of calcitriol, the active form of vitamin D. Reduced calcitriol impairs intestinal calcium absorption and removes part of the normal suppression of parathyroid hormone production. Phosphate retention and a tendency toward lower calcium further stimulate PTH secretion, producing secondary hyperparathyroidism. Persistent PTH excess increases bone turnover and calcium mobilization from bone, contributing to skeletal weakness and fracture risk. Calcium and phosphate values vary with disease stage and treatment: phosphate can remain normal earlier in CKD, while calcium-containing binders or active vitamin D can contribute to hypercalcemia during treatment.
Apply it
An adult with advanced CKD has calcium 8.1 mg/dL, phosphate 6.2 mg/dL, and PTH rising from 220 to 480 pg/mL; the laboratory's PTH upper limit is 65 pg/mL. Low calcium, elevated phosphate, and rising PTH fit kidney-related secondary hyperparathyroidism. Review phosphate intake, binder use, vitamin D status, and treatment together. The pattern supports the mechanism but does not independently establish the patient's bone histology.
Common pitfall: Do not require every patient to have low calcium and high phosphate before recognizing CKD-MBD. Compensatory hormone responses and treatment can change those values. Conversely, hypercalcemia during therapy does not demonstrate healthy bone balance. Interpret serial calcium, phosphate, and PTH together; excessive PTH suppression can also produce an undesirable bone-turnover pattern.
Mineral & Bone Disorder in Chronic Kidney Disease - NIDDK · KDIGO — Summary of 2017 CKD-MBD Guideline Recommendations
45.How does CKD disrupt mineral and bone regulation?
Declining kidney function disrupts phosphate handling and vitamin D metabolism, altering the signals that regulate calcium, phosphate, and parathyroid hormone. These changes can affect bone turnover and contribute to calcification outside bone. CKD-mineral and bone disorder is therefore a systemic regulatory problem rather than an isolated high-phosphate result. Interpretation should integrate the related biochemical findings and their direction over time. A normal value in one component does not establish that the entire system is balanced.
Apply it
A patient asks why several mineral tests are ordered when only phosphate was discussed previously. Explain that calcium, phosphate, and PTH describe interacting parts of a regulatory system and must be considered together during assessment.
Common pitfall: Do not reduce CKD-mineral and bone disorder to dietary phosphorus alone. Hormonal changes, treatment effects, and calcium balance also shape the clinical picture.
46.Why should calcium, phosphate, and PTH be interpreted as trends?
KDIGO recommends basing CKD-mineral and bone disorder treatment on serial assessments of phosphate, calcium, and PTH considered together. A single result may reflect temporary variation, recent treatment, or measurement conditions. Trends reveal persistence and show whether improving one component is worsening another. The discriminating task is to recognize the combined pattern rather than chase an isolated number. Clinical decisions should reflect the magnitude, persistence, and direction of abnormalities within the patient's overall context.
Apply it
Phosphate improves after a treatment change, but repeated calcium measurements rise. Present both trends during review rather than reporting success based only on phosphate, because the combined biochemical response may require a different plan.
Common pitfall: Avoid treating each laboratory result as an independent target. A strategy that improves phosphate can still produce an unfavorable calcium or PTH pattern.
47.Why does hypercalcemia matter when selecting phosphate-lowering therapy?
Some phosphate binders add calcium while reducing intestinal phosphate absorption. In an adult with CKD, persistent hypercalcemia makes the calcium load clinically important rather than an incidental laboratory finding. KDIGO advises avoiding hypercalcemia and restricting calcium-based binder exposure in relevant phosphate-lowering treatment decisions. The therapeutic objective is not simply lower phosphate at any cost. Review calcium trends, the current binder, and other mineral therapies together when assessing whether the regimen remains appropriate.
Apply it
A patient's phosphate remains elevated while calcium is repeatedly high on a calcium-containing binder. Flag the combined findings for regimen review rather than assuming that increasing the same binder is the safest next step.
Common pitfall: Do not assume a calcium-containing product is harmless because calcium is a nutrient. Its therapeutic load matters when the patient already has repeated hypercalcemia.
48.How can reduced kidney function contribute to metabolic acidosis?
The kidneys contribute to acid-base balance by excreting acid and maintaining bicarbonate. Reduced function can impair these processes and produce metabolic acidosis. A low bicarbonate result should be interpreted with the clinical setting and other possible causes, including gastrointestinal losses or acute illness. Persistent acidosis can have systemic consequences and warrants assessment. The discriminating principle is that a compatible CKD mechanism does not eliminate the need to investigate a sudden or disproportionate change.
Apply it
A patient with stable CKD develops a new low bicarbonate after several days of diarrhea. Consider both reduced renal acid handling and gastrointestinal bicarbonate loss instead of assuming the new result reflects CKD progression alone.
Common pitfall: Do not infer the severity or cause of acid-base disturbance from one value without context. Acute illness can add a second process to chronic kidney impairment.
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
49.Why are NSAIDs especially concerning during dehydration?
NSAIDs can reduce the kidney's ability to maintain blood flow, especially when circulating volume or blood pressure is reduced. Dehydration from vomiting, diarrhea, or poor intake therefore increases the risk of acute kidney injury. Patients may overlook this risk because these medicines are available without a prescription and may be contained in combination products. Medication review should identify the actual ingredients and the acute illness context, rather than relying only on the patient's prescription list.
Apply it
A patient with CKD and several days of diarrhea takes ibuprofen for body aches. Identify the combination of reduced intake, fluid loss, and NSAID exposure as a kidney safety concern requiring prompt medication and clinical review.
Common pitfall: Nonprescription availability does not establish kidney safety. Asking only about prescribed medicines can miss the product most relevant to an acute decline in kidney function.
50.How should patients prepare a medicine plan for acute illness?
Acute illnesses that cause dehydration or low blood pressure can change medication safety. Patients benefit from a personalized plan developed with their clinician or pharmacist that identifies whom to contact, which medicines require review, and how treatment will be restarted or monitored if changes are needed. The plan should include nonprescription products and supplements. It should replace improvised decisions during illness with clear instructions tailored to the person's conditions and current medication regimen.
Apply it
A patient asks whether all regular medicines should be stopped whenever vomiting occurs. Help arrange a specific illness plan that addresses the actual medicines, hydration concerns, contact instructions, and reassessment rather than giving a blanket rule.
Common pitfall: Avoid indefinite or universal medication-stop advice. Temporary changes can carry risks, and a safe plan must include follow-up and clear instructions about resumption.
Chronic HD Unit (AKI & DGF)8%
51.When is kidney replacement therapy urgently indicated in AKI?
Urgent kidney replacement therapy is considered when life-threatening disturbances of fluid, electrolytes, or acid-base balance cannot be adequately controlled otherwise. Examples include dangerous hyperkalemia, severe acidosis, and pulmonary edema unresponsive to appropriate treatment. KDIGO emphasizes the broader clinical context and laboratory trends rather than a single creatinine or urea threshold. The decisive feature is the complication and its severity, not merely the presence of AKI or an impressive isolated laboratory number.
Apply it
A patient with AKI has worsening pulmonary edema and hypoxemia despite medical treatment. Recognize a possible urgent kidney replacement indication and escalate promptly rather than waiting for creatinine to reach a predetermined numerical threshold.
Common pitfall: Do not make dialysis urgency depend on creatinine alone. Severe complications can require treatment before an arbitrarily selected laboratory value has been reached.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
52.Which changes meet the published KDIGO definition of AKI?
The published KDIGO definition includes a creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/hour for six hours. These are alternative criteria rather than requirements that must all be present. Accurate baseline information and timed urine measurement matter. A creatinine still within a laboratory reference interval can nevertheless represent a clinically important acute rise.
Apply it
An adult's creatinine rises from 0.8 to 1.2 mg/dL within 36 hours. Recognize that the 0.4 mg/dL increase meets the creatinine-change criterion even if the latest result appears only mildly abnormal.
Common pitfall: Do not wait for both oliguria and creatinine elevation. Either qualifying criterion can identify AKI, and a reference range does not replace comparison with baseline.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
53.How is kidney recovery assessed during dialysis-requiring AKI?
Recovery assessment asks whether intrinsic kidney function can meet the patient's fluid and metabolic needs without ongoing dialysis. Urine output, interdialytic laboratory trends, volume status, and the overall clinical course contribute. A lower creatinine immediately after dialysis reflects extracorporeal removal and does not by itself prove recovery. Likewise, increased urine volume may not establish adequate solute clearance. Decisions to discontinue treatment require integrated reassessment of endogenous function and the original reason dialysis was needed.
Apply it
A patient produces more urine, but potassium rises again between treatments. Report both findings during recovery assessment rather than assuming urine volume alone means dialysis can stop and metabolic needs are now being met.
Common pitfall: Do not mistake the effect of dialysis for restored kidney function. Posttreatment laboratory improvement must be distinguished from sustained control between treatments without extracorporeal support.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
54.What does delayed graft function mean after kidney transplantation?
Delayed graft function means a transplanted kidney does not begin working adequately straight away. The recipient may need temporary dialysis while the graft recovers, and close monitoring helps assess function and investigate causes of poor performance. It does not automatically mean irreversible graft loss or rejection. Urine output, blood tests, and transplant-team evaluation guide care. Dialysis staff should communicate relevant changes because the patient's function and treatment requirements may evolve over a short period.
Apply it
A recent transplant recipient needs dialysis and fears the kidney has permanently failed. Explain that delayed graft function can require temporary support while emphasizing the need for close monitoring and coordination with the transplant team.
Common pitfall: Do not reassure by guaranteeing recovery or diagnose rejection from dialysis dependence alone. Delayed function requires investigation, and its course varies between individual recipients.
55.Why is follow-up needed after apparent AKI recovery?
An episode of AKI can be followed by incomplete recovery or increased risk of later CKD, even when dialysis is no longer needed. KDIGO recommends evaluating patients three months after AKI for resolution, new CKD, or worsening pre-existing CKD. Earlier review may also be needed according to the clinical course. Follow-up should connect current kidney function, blood pressure, medication safety, and ongoing monitoring rather than ending kidney care when the acute treatment stops.
Apply it
A patient discharged after dialysis-requiring AKI believes no further kidney review is necessary because urine output returned. Explain the need for reassessment and ensure the discharge plan includes kidney follow-up and review of current medicines.
Common pitfall: Stopping dialysis does not prove complete recovery or eliminate future risk. Avoid allowing the acute episode to disappear from the patient's ongoing clinical history.
KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
Water for Dialysis8%
56.Why is ordinary drinking-water quality insufficient for dialysis?
Hemodialysis exposes patients indirectly to large volumes of water through dialysate and a semipermeable membrane. Substances acceptable for drinking may therefore create a different risk during dialysis. Water must undergo treatment and monitoring appropriate to dialysis use, including chemical and microbiological hazards. Municipal potability does not demonstrate suitability for the dialysis system. Safety depends on the incoming supply, treatment barriers, monitoring results, and maintained performance of the complete system.
Apply it
A municipal notice states that tap water remains safe to drink after a treatment change. Explain why the dialysis unit must still evaluate the change against its own water-treatment requirements before assuming patient treatment can proceed safely.
Common pitfall: Do not use taste, clarity, or drinking-water approval as a dialysis safety test. Chemical and microbial hazards may be present without visible warning signs.
57.How do sampling location and total chlorine results determine the breakthrough response?
Under 42 CFR 494.40(b), total chlorine at or above 0.1 mg/L after the initial carbon component triggers immediate testing after the backup component. Initial-component breakthrough alone does not establish final-water failure. An unacceptable final-component result requires immediate correction with testing to verify effectiveness, or treatment termination to prevent exposure, plus immediate medical-director notification. CMS specifies testing before initial treatments and each shift, or approximately every four hours without set shifts. Changed municipal disinfection can increase the load on carbon barriers.
Apply it
A sample between primary and backup carbon tanks measures 0.15 mg/L: test after the backup tank immediately. If that final sample is 0.14 mg/L, prevent exposure, implement correction with verification or terminate treatment, and notify the medical director.
Common pitfall: A result without a sampling location is incomplete. An acceptable backup result requires the breakthrough contingency plan, corrective action, and increased surveillance; it does not restore the exhausted primary barrier.
Federal Register :: Request Access · qso-26-09-esrd-original-release-date-2026-05-15.pdf · CDC — Water Use in Dialysis
58.How do dialysis water-treatment barriers perform different jobs?
A dialysis water system uses complementary barriers rather than one device that removes every hazard. Carbon treatment addresses chlorine and chloramine, softening reduces hardness, and reverse osmosis reduces many dissolved contaminants and microorganisms. The actual arrangement depends on system design and feed water. Each stage must be assessed for its intended function. A satisfactory result from one component cannot prove that another component is working or that the entire downstream system remains safe.
Apply it
A colleague argues that normal reverse-osmosis operation makes carbon monitoring unnecessary. Explain the distinct contaminant-control roles and why acceptable performance of one treatment stage does not eliminate verification of another stage's protective function during dialysis.
Common pitfall: Do not treat all water alarms or tests as interchangeable. Identify the hazard and the barrier being evaluated before interpreting a result or response.
CDC — Environmental Infection Control: Water · CDC — Water Use in Dialysis
59.How should bacterial and endotoxin results be interpreted against action and allowable levels?
Culture measures recoverable bacterial growth; endotoxin testing measures inflammatory bacterial components. Under the US CMS-incorporated AAMI RD52:2004 framework, bacterial action begins at 50 CFU/mL and endotoxin action at 1 EU/mL; allowable levels are below 200 CFU/mL and below 2 EU/mL. Corrective action begins at action levels, before allowable limits are reached. Stricter adopted standards must be identified separately: CDC's comparison lists ANSI/AAMI/ISO 13959:2014 water limits below 100 CFU/mL and below 0.25 EU/mL, with action levels of 50 CFU/mL and 0.125 EU/mL.
Apply it
At a distribution-loop sampling port, water yields 70 CFU/mL and 1.2 EU/mL. Under RD52:2004, both exceed action levels while remaining below allowable limits: initiate corrective action, investigate, and verify the response. Under the cited ISO framework, 1.2 EU/mL also exceeds the allowable endotoxin level.
Common pitfall: Do not wait for 200 CFU/mL or 2 EU/mL before acting under RD52:2004. A favorable culture cannot cancel an abnormal endotoxin result, and limits must match the named standard and sample type.
CDC — Water Use in Dialysis · Federal Register :: Request Access · CDC — Environmental Infection Control: Water
60.How can distribution piping undermine otherwise effective water treatment?
Treated water can become contaminated after leaving the treatment equipment. Distribution-system design, stagnation, surfaces that support biofilm, and inadequate disinfection can allow microorganisms to persist or regrow downstream. Sampling only at the treatment outlet can therefore miss hazards closer to patient use. System assessment must include distribution and relevant endpoints, not just production equipment. A satisfactory upstream result and an abnormal downstream result suggest that contamination may be occurring within the intervening system.
Apply it
Samples at the treatment outlet remain satisfactory, but repeated samples near a distant station are abnormal. Investigate the distribution pathway, sampling technique, and disinfection performance rather than assuming the upstream result proves the endpoint is safe.
Common pitfall: Do not assume contaminants enter only with municipal feed water. The dialysis distribution system can become a continuing source even when upstream treatment performs appropriately.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give ESRD unit care the largest share of study time: connect diffusion, ultrafiltration, treatment duration, access assessment, infection prevention, and delivered adequacy.
- Practise fluid calculations with explicit assumptions, then distinguish correct arithmetic from a clinically tolerable treatment plan.
- Rehearse medication-specific assessments: heparin bleeding and HIT precautions, ESA blood-pressure and hemoglobin review, intravenous-iron reaction recognition, and binder administration with food.
- Interpret adult kidney disease through chronicity, CGA classification, paired laboratory findings, medication exposure, and trends rather than isolated results.
- Distinguish cardiac protection, intracellular potassium redistribution, and potassium removal during emergency hyperkalemia treatment; include glucose and potassium reassessment.
- Distinguish dialysis-supported laboratory improvement from intrinsic recovery in AKI and delayed graft function.
- Interpret water results using the sampling location, named standard, units, action levels, allowable limits, and staged carbon-breakthrough response.
- Apply teaching, medication safety, infection control, and interdisciplinary problem-solving across all four domains.
A practical preparation plan
1. Map the complete outline
Read the April 2026 blueprint and specifications effective September 1, 2026. Mark strengths and gaps within all four domains and seven cross-cutting objectives; use the official outline to extend beyond these selected concepts.
2. Work through patient decisions
For each concept, identify the mechanism, decisive cue, likely competing explanation, and appropriate next assessment or intervention. Include medication-specific precautions and monitoring alongside volume status, access changes, and laboratory trends.
3. Calculate and interpret
Practise planned fluid removal, average ultrafiltration rate, URR, and CKD categories. Interpret numerical water results against an explicitly named framework. State units and assumptions, then explain what the result establishes and which clinical questions remain unanswered.
4. Complete the independent questions
Answer all 20 questions before reviewing explanations. For each error, explain why the selected option was tempting and identify the cue that favors the best answer; record the relevant domain and objective.
5. Rehearse recall and communication
Use the flashcards until you can explain the reasoning without recognition cues. Practise short patient explanations about binder timing, access protection, fluid sources, medicine safety, and temporary dialysis after transplantation.
6. Close the remaining gaps
Return to the official references and outline for topics not fully covered here. Review the issuer's current examination instructions separately, and base final study priorities on unresolved knowledge gaps rather than a score from this short drill.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- NNCC — CDN
- CDN New Test Blueprint
- Certified Dialysis Nurse Examination — Weights for Blueprint Categories
- NNCC Certification Examination Application Booklet — Revised June 2026
- Important Information Regarding CNN and CDN Examination Changes — January 15, 2026
- Attention All Current CDN and CNN Certificants — January 19, 2026
- NIDDK — Hemodialysis
- KDIGO — Blood Pressure and Volume Management in Dialysis
- National Kidney Foundation — Hemodialysis Access
- CDC — Best Practices for Bloodstream Infection Prevention in Dialysis Setting
- CDC — Infections and Patients on Dialysis
- NIDDK — Treat Complications & Comorbidities
- NIDDK — Eating & Nutrition for Hemodialysis
- National Kidney Foundation — Hemodialysis: How It Works, Types, and What to Expect
- NIDDK — Lesson 5: Getting Ready for Treatment
- National Kidney Foundation — Fluid Overload in a Dialysis Patient
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
- NIDDK — Anemia in Chronic Kidney Disease
- KDIGO — Summary of 2017 CKD-MBD Guideline Recommendations
- National Kidney Foundation — High Potassium: Causes, Symptoms, and Treatment
- NIDDK — Keeping Kidneys Safe: Smart Choices about Medicines
- NIDDK — Chronic Kidney Disease Tests & Diagnosis
- KDIGO — Acute Kidney Injury and Acute Kidney Disease
- KDIGO 2012 Clinical Practice Guideline for Acute Kidney Injury
- NHS Blood and Transplant — Delayed Graft Function
- CDC — Water Use in Dialysis
- CDC — Environmental Infection Control: Water
- Hemodialysis Access | National Kidney Foundation
- Federal Register :: Request Access
- qso-26-09-esrd-original-release-date-2026-05-15.pdf
- KDIGO-2026-Anemia-in-CKD-Guideline.pdf
- DailyMed - SEVELAMER CARBONATE tablet, film coated
- Special circumstances Guidelines | Resuscitation Council UK
- Mineral & Bone Disorder in Chronic Kidney Disease - NIDDK
- DailyMed - HEPARIN SODIUM injection, solution
- DailyMed - EPOGEN- epoetin alfa solution
- DailyMed - VENOFER- iron sucrose injection, solution
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.